We are live on
!
Find out more
TCP
Tourbillon Capital Partners Portfolio holdings
AUM
$6.26M
1-Year Est. Return
42.29%
This Fund
S&P 500
This Quarter
Est. Return
+2.51%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$183M
(-6.8%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-5.3%
Top 10 Holdings %
Top 10 Hldgs %
47.07%
Holding
81
New
34
Increased
7
Reduced
14
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autodesk
ADSK
|
+$93.5M |
| 2 |
Broadcom
AVGO
|
+$75.4M |
| 3 |
Alibaba
BABA
|
+$67.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$66.4M |
| 5 |
LPL Financial
LPLA
|
+$62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spectrum Brands
SPB
|
+$136M |
| 2 |
Cognizant
CTSH
|
+$66.1M |
| 3 |
Synchrony
SYF
|
+$65.9M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$61.3M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$53.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Technology | 11.63% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Financials | 9% |
| 5 | Consumer Staples | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
iQIYI
IQ
$1.24B
| $3.89M | 0.15% |
+250,000
| New | +$3.89M |
|
52
General Mills
GIS
$19.3B
| $3.38M | 0.13% |
+75,000
| New | +$4.07M |
|
|
LOXO
53
PUT
DELISTED
Loxo Oncology, Inc
LOXO
| $2.88M | 0.11% |
+25,000
| New | +$2.66M |
|
54
Krystal Biotech
KRYS
$9.55B
| $2.55M | 0.1% |
252,348
| – | – |
|
|
NITE
55
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $2.45M | 0.1% |
170,952
| – | – |
|
|
PVLA
56
Palvella Therapeutics
PVLA
$2.23B
| $2.01M | 0.08% |
+3,689
| New | +$2.28M |
|
57
PUT
Editas Medicine
EDIT
$445M
| $1.66M | 0.07% |
+50,000
| New | +$1.78M |
|
58
PUT
CRISPR Therapeutics
CRSP
$4.99B
| $1.6M | 0.06% |
+35,000
| New | +$1.44M |
|
59
CALL
Boston Scientific
BSX
$71.4B
| – | – |
-165,200
| Closed | -$4.09M |
|
|
60
Boston Scientific
BSX
$71.4B
| – | – |
-450,000
| Closed | -$11.2M |
|
|
61
Cognizant
CTSH
$25.6B
| – | – |
-930,803
| Closed | -$66.1M |
|
62
PUT
HCA Healthcare
HCA
$88.5B
| – | – |
-500,000
| Closed | -$43.9M |
|
63
Incyte
INCY
$24B
| – | – |
-294,607
| Closed | -$27.9M |
|
64
Merck
MRK
$317B
| – | – |
-445,400
| Closed | -$24.1M |
|
65
Newmark Group
NMRK
$2.66B
| – | – |
-50,000
| Closed | -$795K |
|
66
Post Holdings
POST
$4.09B
| – | – |
-191,283
| Closed | -$9.92M |
|
67
Republic Services
RSG
$64.5B
| – | – |
-200,000
| Closed | -$13.5M |
|
68
PUT
Sarepta Therapeutics
SRPT
$1.77B
| – | – |
-1,100,000
| Closed | -$61.2M |
|
|
69
Synchrony
SYF
$25.6B
| – | – |
-1,706,897
| Closed | -$65.9M |
|
70
Voyager Therapeutics
VYGR
$189M
| – | – |
-230,000
| Closed | -$3.82M |
|
71
CALL
Warner Bros
WBD
$66.2B
| – | – |
-1,325,000
| Closed | -$29.7M |
|
|
72
Warner Bros
WBD
$66.2B
| – | – |
-834,179
| Closed | -$18.7M |
|
73
CALL
Corpay
CPAY
$26B
| – | – |
-450,000
| Closed | -$86.6M |
|
|
GBT
74
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-125,787
| Closed | -$4.95M |
|
|
RDUS
75
CALL
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-500,000
| Closed | -$15.9M |
|
Similar funds
BC
LBG
TGA
ACM
MGFS
LA
CT
NMM
Tourbillon Capital Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Tourbillon Capital Partners held 81 positions worth $2.52B, down 6.8% from $2.7B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Tourbillon Capital Partners withdrew a net $134M in Q1 2018, closing 23 positions and reducing 14 holdings. Its most notable exit was Cognizant, an estimated $66.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Tourbillon Capital Partners opened a new position in Autodesk worth $98.6M.
- Tourbillon Capital Partners's largest Q1 2018 buy was Autodesk: 785,400 shares worth $98.6M.
- Tourbillon Capital Partners added most to Humana in Q1 2018, an estimated $40.6M increase.
- Tourbillon Capital Partners's biggest Q1 2018 reduction was Spectrum Brands, cutting an estimated $136M.
- Tourbillon Capital Partners fully exited Cognizant in Q1 2018, selling an estimated $66.1M.
- Tourbillon Capital Partners's ten largest holdings make up 47% of its $2.52B portfolio in Q1 2018.
- Tourbillon Capital Partners opened 34 new positions and closed 23 in Q1 2018.
- Tourbillon Capital Partners's portfolio value fell 6.8% quarter-over-quarter to $2.52B.
Based on Tourbillon Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.